China Pharma (NYSE:CPHI) Stock Price Down 6.4% – What’s Next?

Shares of China Pharma Holdings, Inc. (NYSE:CPHI – Get Free Report) dropped 6.4% on Friday. The stock traded as low as $0.4987 and last traded at $0.5240. Approximately 44,600 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 1,838,766 shares. The stock had previously closed at $0.5599.

China Pharma Stock Down 6.4%

The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. The company has a market capitalization of $22.54 million, a P/E ratio of -1.22 and a beta of 0.95. The stock has a 50-day moving average price of $0.69 and a 200-day moving average price of $0.80.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc. develops, manufactures and sells pharmaceutical products in China through its operating subsidiaries. Its products are used to treat a range of conditions, including infections and disorders affecting the cardiovascular, respiratory and digestive systems. The company sells medicines in various dosage forms, including tablets, capsules, injections and powders. Its customers include hospitals, pharmaceutical distributors and retail pharmacies in China.

Recommended Stories

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.